News & Updates
Filter by Specialty:
Hair cortisol, cortisone unrelated to cognitive function, dementia
There appears to be no longitudinal association between hair cortisol and cortisone levels with dementia and various measures of cognitive function, a recent study has found.
Hair cortisol, cortisone unrelated to cognitive function, dementia
06 Dec 2022
Itraconazole effective for ringworm of the body but requires longer treatment
Itraconazole appears to be effective in the treatment of patients with tinea corporis/cruris (TCC) or ringworm of the body, as shown in a study. However, the treatment duration needs to be longer and, even with successful treatment, many patients experience relapse.
Itraconazole effective for ringworm of the body but requires longer treatment
06 Dec 2022
Lecanemab moderately slows decline in early AD, associated with AEs
Lecanemab reduces brain amyloid burden and offers moderate slowing of cognitive decline in early Alzheimer’s disease (AD), but is associated with adverse events (AEs), according to the results of the phase III, double-blind, placebo-controlled CLARITY AD trial, presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD 2022) conference.
Lecanemab moderately slows decline in early AD, associated with AEs
06 Dec 2022
Stroke up 30 percent since 2001 in HK’s ≤55-year-olds
Researchers from the University of Hong Kong (HKU) report that the incidence of “young stroke” (ie, strokes occurring in those aged 18–55 years) has increased by 30 percent in Hong Kong’s residents since 2001.
Stroke up 30 percent since 2001 in HK’s ≤55-year-olds
05 Dec 2022
Dose reduction needed in HFrEF patients on sacubitril-valsartan
Some patients with heart failure with reduced ejection fraction (HFrEF) need a loop diuretic dose reduction within 2‒3 months following initiation of sacubitril-valsartan, suggests a study.